Biocon
Mukesh Kamath has over a decade of experience in finance, having served in various managerial roles at Biocon from January 2004 to March 2014, including positions as Deputy Manager, Assistant General Manager, and ultimately as Director General Manager of Finance. Additionally, Mukesh worked as Senior Manager Finance at Clinigene International Ltd from January 2008 to July 2011. Mukesh holds a Bachelor of Commerce degree from Tunga College, Thirthahalli, completed between January 1990 and January 2003.
This person is not in any teams
This person is not in any offices
Biocon
22 followers
Biocon Limited is a biopharmaceutical company. The Company focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The Company has developed and taken a range of Novel Biologics, Biosimilars, differentiated Small Molecules and affordable Recombinant Human Insulin and Analogs from Lab to Market. The Company's brands include INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab) and ALZUMAb (Itolizumab), an anti-CD6 monoclonal antibody. It has a pipeline of Biosimilars and Novel Biologics at various stages of development, including Insulin Tregopil, an oral insulin analog.